Vista simple de metadatos

dc.contributorOxford University Presses_CL
dc.contributor.authorAguilera, Sergio [Chile. Clínica INDISA]es_CL
dc.contributor.authorBrockhausen, Inka [Canadá. Queens University]es_CL
dc.contributor.authorMolina, Claudio [Chile. Universidad Mayor]es_CL
dc.contributor.authorGonzález, Sergio [Chile. Universidad Mayor]es_CL
dc.date.accessioned2018-09-07T13:04:15Z
dc.date.available2018-09-07T13:04:15Z
dc.date.issued2012es_CL
dc.identifier.citationCastro, I., Aguilera, S., Brockhausen, I., Alliende, C., Quest, A. F., Molina, C., ... & Sánchez, M. (2011). Decreased salivary sulphotransferase activity correlated with inflammation and autoimmunity parameters in Sjögren's syndrome patients. Rheumatology, 51(3), 482-490.es_CL
dc.identifier.issnISSN 1462-0324es_CL
dc.identifier.issnESSN 1462-0332es_CL
dc.identifier.urihttps://academic.oup.com/rheumatology/article-pdf/51/3/482/5086922/ker351.pdfes_CL
dc.identifier.urihttps://doi.org/10.1093/rheumatology/ker351es_CL
dc.identifier.urihttp://repositorio.umayor.cl/xmlui/handle/sibum/2661
dc.description.abstractOBJECTIVES: To determine the expression and enzymatic activities of sulphotransferases involved in mucin hyposulphation in labial salivary glands (LSGs) from SS patients and to correlate sulphotransferase activity with clinical parameters such as secretion, inflammation and serology. METHODS: LSG from 31 SS patients and 31 control subjects were studied. Relative mRNA and protein levels of Gal3-O-sulphotransferases (Gal3STs) and β1,3-galactosyltransferase-5 (β3GalT5) were determined by quantitative RT-PCR and western blotting, respectively. Enzymatic activities were quantified using radioactively labelled donor substrates and specific acceptor substrates. Products were purified by chromatography. Spearman's correlation analysis was used to compare data. RESULTS: The levels of Gal3ST activity were significantly decreased in SS patients, without changes in mRNA and protein levels, while the enzymatic activities of glycosyltransferases involved in mucin glycosylation were similar in both groups. An inverse correlation was observed between Gal3ST activity and glandular function measured by scintigraphy, but not with unstimulated salivary flow. Gal3ST activity was inversely correlated with focus score, TNF-α levels and presence of the autoantibodies Ro/SS-A and La/SS-B. CONCLUSION: The decrease in sulphotransferase activity provides an explanation for mucin hyposulphation observed in the LSGs from SS patients. The decrease in Gal3STs activity was not a consequence of reduced gene expression, but probably due to alterations in the enzyme activity regulation. Interestingly, the levels of sulphotransferase activity detected correlated well with secretory function, inflammation and serology. Finally, we postulate that pro-inflammatory cytokines induced by autoantibodies, such as Ro/SS-A and La/SS-B in SS patients, may modulate Gal3ST activity, thereby altering mucin quality and leading to mouth dryness.es_CL
dc.description.sponsorshipEste trabajo fue financiado por: grants FONDECYT-CHILE 1080006; FONDAP 15010006; Canadian Cystic Fibrosis Foundation.es_CL
dc.format.extentARTÍCULO ORIGINALes_CL
dc.language.isoenes_CL
dc.publisherCIENCIASes_CL
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chilees_CL
dc.subjectREUMATOLOGÍAes_CL
dc.titleDecreased salivary sulphotransferase activity correlated with inflammation and autoimmunity parameters in Sjogren's syndrome patientses_CL
dc.typeArtículo o Paperes_CL
umayor.indizadorCOTes_CL
umayor.politicas.sherpa/romeoLicencia color: AMARILLO (Puede archivar el pre-print (ie la versión previa a la revisión por pares))--Pre-print del autor: el autor puede archivar la versión pre-print (ie la versión previa a la revisión por pares) Post-print del autor: el autor puede archivar la versión post-print (ie la versión final posterior a la revisión por pares) siempre que se cumplan las restricciones: 12 meses de embargo Versión de editor/PDF: cross el autor no puede archivar la versión del editor/PDF. Condiciones generales: El pre-print sólo puede depositarse antes de la aceptación, El pre-print debe acompañarse de una declaración establecida (ver enlace), El pre-print no debe reemplazarse por el post-print, sino que se enlazará a la versión publicada con una declaración establecida corregida, Pre-print on author's personal website, employer website, free public server or pre-prints in subject area, Post-print in Institutional repositories or Central repositories, La versión de editor/PDF no puede utilizarse, La fuente editorial debe reconocerse, Debe ir enlazado a la versión de editor, La copia archivada debe acompañarse de la frase establecida (ver Política), Eligible authors may deposit in OpenDepot, El editor depositará copia en PubMed Central en nombre de los autores financiados por el NIH// Disponible en: http://www.sherpa.ac.uk/romeo/issn/1462-0324/es/es_CL
umayor.indexadoWOSes_CL
umayor.indexadoSCOPUSes_CL
dc.identifier.doi10.1093/rheumatology/ker351es_CL]
umayor.indicadores.wos-(cuartil)Q1es_CL
umayor.indicadores.scopus-(scimago-sjr)sin informaciónes_CL


Vista simple de metadatos



Modificado por: Sistema de Bibliotecas Universidad Mayor - SIBUM
DSpace software copyright © 2002-2018  DuraSpace